5240 studies found for:    stem cell
Show Display Options
Rank Status Study
41 Completed Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome
Condition: Limbus Corneae Insufficiency Syndrome
Intervention: Procedure: Stem Cell with Amniotic Membrane Transplant
42 Completed Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: intravenous injection of mesenchymal stem cells;   Biological: injection of cell free media
43 Recruiting Stem Cell Ophthalmology Treatment Study
Conditions: Retinal Disease;   Macular Degeneration;   Hereditary Retinal Dystrophy;   Optic Nerve Disease;   Glaucoma
Interventions: Procedure: RB (Retrobulbar);   Procedure: ST (Subtenon);   Procedure: IV (Intravenous);   Procedure: IVIT (Intravitreal);   Procedure: IO (Intraocular)
44 Recruiting Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host Disease
Condition: Acute Graft-versus-host Disease
Interventions: Biological: Mesenchymal stem cells;   Biological: Non-mesenchymal stem cells
45 Completed Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
Conditions: Stem Cell Transplantation;   Leukemia
Interventions: Drug: Fludarabine;   Drug: Busulfan;   Drug: Thymoglobulin;   Drug: Azacitidine;   Procedure: Stem Cell Transplant
46 Active, not recruiting HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies
Conditions: Acute Myeloid Leukemia;   Acute Lymphocytic Leukemia;   Myelodysplasia;   Chronic Myeloid Leukemia;   Histiocytosis
Interventions: Drug: Chemotherapy and antibodies;   Device: Miltenyi Biotec CliniMACS;   Procedure: Allogeneic stem cell transplantation
47 Recruiting Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease
Condition: Chronic Graft-versus-host Disease
Interventions: Biological: Mesenchymal stem cells;   Biological: Non-mesenchymal stem cells
48 Completed
Has Results
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin
Conditions: Stem Cell Transplantation;   Leukemia
Interventions: Drug: Plerixafor;   Drug: Filgrastim;   Drug: Fludarabine;   Drug: Busulfan;   Procedure: Allogeneic blood stem cell transplant;   Drug: ATG (Thymoglobulin)
49 Recruiting To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients
Condition: Renal Transplant Rejection
Intervention: Biological: Mesenchymal Stem Cells
50 Terminated
Has Results
Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft
Conditions: ALL;   ANLL;   MDS;   NHL
Interventions: Procedure: Naive T-cell Depleted Stem Cell Transplant;   Procedure: Stem Cell Transplant No Manipulation;   Device: Isolex device from Baxter
51 Terminated
Has Results
Stem Cell Transplantation for Children Affected With Osteopetrosis
Condition: Osteopetrosis
Interventions: Procedure: Stem Cell Transplantation;   Device: Miltenyi Biotec CliniMACS;   Drug: Systemic chemotherapy and antibodies
52 Recruiting Hematopoietic Stem Cell Support in Vasculitis
Condition: Vasculitis
Interventions: Biological: Autologous Stem Cell Transplant;   Biological: Allogeneic Stem Cell Transplant
53 Unknown  IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting
Conditions: Heart Failure;   Heart Attack;   Coronary Artery Bypass Surgery
Intervention: Biological: Injection of autologous CD133+ stem cells at the time of coronary artery bypass grafting
54 Active, not recruiting
Has Results
Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis (FOCUS Br)
Condition: Coronary Artery Disease
Interventions: Biological: Stem Cell Therapy;   Other: Control (plasma)
55 Enrolling by invitation The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Procedure: stem cell transplantation
56 Active, not recruiting Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation
Conditions: Diffuse Large Cell Lymphoma;   Lymphoma
Interventions: Drug: Zevalin;   Drug: Carmustine;   Drug: Etoposide;   Drug: Cytarabine;   Drug: Melphalan;   Drug: Rituximab;   Procedure: Stem Cell Transplant
57 Unknown  Role of Stem Cells in Improving Implantation Rates in ICSI Patients
Condition: Assess the Efficacy of Differentiated and Undifferentiated Stem Cell Therapy in Improving Endometrial Receptivity.
Interventions: Biological: Differentiated stem cells to endometrium is deposited in the uterine cavity through an IUI catheter;   Biological: Undifferentiated MSC is deposited in the uterine cavity through an IUI catheter.
58 Completed AutoLogous Human CArdiac-Derived Stem Cell to Treat Ischemic cArdiomyopathy (ALCADIA)
Conditions: Congestive Heart Failure;   Ischemic Cardiomyopathy;   Ventricular Dysfunction
Intervention: Procedure: human cardiac stem cells
59 Terminated The Application of Cultured Cornea Stem Cells in Patients Suffering From Corneal Stem Cell Insufficiency
Condition: Unilateral Limbal Stem Cell Insufficiency
Intervention: Procedure: Transplant of cultured limbal stem cells on cornea
60 Withdrawn Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma
Conditions: Adult Supratentorial Primitive Neuroectodermal Tumor (PNET);   Ewing Sarcoma of Bone;   Extraosseous Ewing Sarcoma;   Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
Interventions: Drug: etoposide;   Drug: ifosfamide;   Radiation: intensity-modulated radiation therapy;   Drug: topotecan hydrochloride;   Drug: busulfan;   Drug: melphalan;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: autologous bone marrow transplantation

First Page    Show previous page of results Previous Page (21-40) Studies Shown (41-60) Next Page (61-80) Show next page of results    Last Page
Indicates status has not been verified in more than two years